Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Sunshine Biopharma Inc. (SBFM)

Pharmaceutical Preparations

https://www.sunshinebiopharma.com

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5).

6500 TRANS-CANADA HIGHWAY, 4TH FLOOR
POINTE-CLAIRE, A8

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/09/2007

Market Cap

3,482,267

Shares Outstanding

25,680,000

Weighted SO

25,678,290

Total Employees

N/A

Upcoming Earnings

08/09/2024

Similar Tickers

SGIOY --.--%

ALIM --.--%

SXTC --.--%

GHSI --.--%

SHPH --.--%

LFCR --.--%

MNK --.--%

DERM --.--%

Beta

-0.9650

Last Div

0.0000

Range

2.42-980.0

Chg

-0.2550

Avg Vol

137041

Mkt Cap

3482267

Exch

NASDAQ

Country

CA

Phone

514 426 6161

DCF Diff

0.0100

DCF

1.0800

Div Yield

0.0000

P/S

0.1302

EV Multiple

3.8670

P/FV

0.0769

Div Yield %

0.0000

P/E

-0.4668

PEG

-0.0052

Payout

0.0000

Current Ratio

4.4129

Quick Ratio

3.2347

Cash Ratio

2.6685

DSO

38.5986

DIO

156.4496

Op Cycle

195.0482

DPO

73.4742

CCC

121.5740

Gross Margin

0.3284

Op Margin

-0.1502

Pretax Margin

-0.1390

Net Margin

-0.1529

Eff Tax Rate

-0.0999

ROA

-0.1281

ROE

-0.1795

ROCE

-0.1584

NI/EBT

1.0999

EBT/EBIT

0.9251

EBIT/Rev

-0.1502

Debt Ratio

0.0192

D/E

0.0247

LT Debt/Cap

0.0196

Total Debt/Cap

0.0241

Int Coverage

-27.6257

CF/Debt

-16.5100

Equity Multi

1.2852

Rec Turnover

9.4563

Pay Turnover

4.9677

Inv Turnover

2.3330

FA Turnover

26.6893

Asset Turnover

0.8383

OCF/Share

-15.7649

FCF/Share

-17.8068

Cash/Share

27.1853

OCF/Sales

-0.3781

FCF/OCF

1.1295

CF Coverage

-16.5100

ST Coverage

-87.6113

CapEx Coverage

-7.7206

Div&CapEx Cov

-7.7206

P/BV

0.0769

P/B

0.0769

P/S

0.1302

P/E

-0.4668

P/FCF

-0.3049

P/OCF

-0.1887

P/CF

-0.1887

PEG

-0.0052

P/S

0.1302

EV Multiple

3.8670

P/FV

0.0769

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 04, 08:30 Sunshine Biopharma Moves Principal Office to New York City

Revenue Product Segmentation